hsa-miR-106b-5p participates in the development of chronic thromboembolic pulmonary hypertension via targeting matrix metalloproteinase 2.

Ran MiaoXingbei DongJuanni GongYing WangXiaojuan GuoYidan LiXiaopeng LiuJun WanJifeng LiSuqiao YangWang WangTuguang KuangJiuchang ZhongZhenguo ZhaiYuanhua Yang

Published in: Pulmonary circulation (2020)

These miRNAs and genes were associated with the pathogenesis of CTEPH. Besides, hsa-miR-106b-5p was involved in the development of CTEPH via targeting MMP2.

Keyphrases

pulmonary hypertension
cancer therapy
genome wide
pulmonary artery
gene expression
pulmonary arterial hypertension
drug delivery
genome wide identification